BRIEF-Qyuns Therapeutics Says Acceptance Of Marketing Authorisation Application & Supplemental Application For QX001S Injection

Reuters
12 Feb
BRIEF-Qyuns <a href="https://laohu8.com/S/LENZ">Therapeutics</a> Says Acceptance Of Marketing Authorisation Application & Supplemental Application For QX001S Injection

Feb 12 (Reuters) - Qyuns Therapeutics Co Ltd 2509.HK:

  • ACCEPTANCE OF MARKETING AUTHORISATION APPLICATION AND SUPPLEMENTAL APPLICATION FOR QX001S INJECTION FOR CROHN'S DISEASE

Further company coverage: 2509.HK

((Reuters.Briefs@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10